• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Integrum

8.07 SEK

+2.67 %

Less than 1K followers

INTEG B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+2.67 %
+7.89 %
+3.46 %
-25.00 %
-27.17 %
-59.54 %
-52.76 %
-86.82 %
-59.50 %

Integrum is active in medical technology. The company develops systems for skeletally anchored prostheses based on the developed OPRA implant system, which is later resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of a large number of patients with amputation. The company was founded in 1998 and has its headquarters in Mölndal.

Read more
Market cap
215.21M SEK
Turnover
2.61M SEK
Revenue
91.39M
EBIT %
-58.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
3/9
2026

Interim report Q1'27

3/12
2026

Interim report Q2'27

4/3
2027

Interim report Q3'27

Regulatory press release13 hours ago

Integrum avser att bolagisera all verksamhet inom bionik under namnet Afyri

Integrum
Regulatory press release13 hours ago

Integrum intends to incorporate all operations within bionics under the name Afyri

Integrum
Regulatory press release6/4/2026, 5:15 AM

BOKSLUTSKOMMUNIKÉ 2025/2026

Integrum

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release6/4/2026, 5:15 AM

YEAR-END REPORT 2025/2026

Integrum
Regulatory press release6/1/2026, 11:35 AM

Integrum bjuder in till presentation av Q4 2025/26

Integrum
Regulatory press release6/1/2026, 11:35 AM

Integrum invites to presentation of Q4 2025/26 results

Integrum
Press release5/5/2026, 1:56 PM

Rättelse: Integrum lanserar digital patientportal i USA för att öka patientflödet och kännedomen om OPRA Implant System

Integrum
Press release5/5/2026, 1:56 PM

Correction: Integrum launches patient-facing website in the US to increase patient flow and awareness of OPRA Implant System

Integrum
Press release5/5/2026, 1:38 PM

Integrum lanserar digital patientportal i USA för att öka patientflödet och kännedomen om OPRA Implant System

Integrum
Press release5/5/2026, 1:38 PM

Integrum launches patient-facing website in the US to increase patient flow and awareness of OPRA Implant System

Integrum
Regulatory press release4/30/2026, 5:56 AM

Integrum AB: Integrum implements a write-down of approximately SEK 7 million following reclassification of certain inventory items

Integrum
Regulatory press release4/30/2026, 5:56 AM

Integrum AB: Integrum genomför nedskrivning om cirka 7 MSEK till följd av omklassificering av vissa lagerposter

Integrum
Press release4/15/2026, 2:36 PM

Integrum AB: Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare

Integrum
Press release4/15/2026, 2:36 PM

Integrum AB: Integrum stärker sin närvaro i Ukraina efter nationellt beslut att utöka användningen av osseointegration i sjukvården

Integrum
Regulatory press release3/5/2026, 6:45 AM

Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26

Integrum
Regulatory press release3/5/2026, 6:45 AM

Integrum AB: Integrum publicerar delårsrapport för tredje kvartalet 2025/26

Integrum
Press release3/3/2026, 5:02 PM

Integrum AB: Integrum invites to presentation of Q3 2025/26 results

Integrum
Press release3/3/2026, 5:02 PM

Integrum AB: Integrum bjuder in till presentation av Q3 2025/26

Integrum
Press release2/20/2026, 8:01 AM

DNB Carnegie Access: Integrum: Discontinuing coverage

Integrum
Regulatory press release2/11/2026, 2:40 PM

Integrum AB: Integrum optimerar organisationen för att ytterligare accelerera kommersialiseringen av OPRA Implant System

Integrum